Cargando…
Baricitinib in severe and refractory peripheral ulcerative keratitis: a case report and literature review
Ocular disease, such as scleritis and peripheral ulcerative keratitis (PUK), may be a serious ocular complication. We present a patient with severe and refractory PUK treated with baricitinib. A review of the literature on Janus kinase inhibitors (JAKINIB) in refractory ocular surface pathology was...
Autores principales: | Calvo-Río, Vanesa, Sánchez-Bilbao, Lara, Álvarez-Reguera, Carmen, Castañeda, Santos, González-Mazón, Iñigo, Demetrio-Pablo, Rosalía, González-Gay, Miguel A., Blanco, Ricardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677317/ https://www.ncbi.nlm.nih.gov/pubmed/36419482 http://dx.doi.org/10.1177/1759720X221137126 |
Ejemplares similares
-
Clinical and immunological study of Tofacitinib and Baricitinib in refractory Blau syndrome: case report and literature review
por: Álvarez-Reguera, Carmen, et al.
Publicado: (2022) -
Adalimumab for refractory peripheral ulcerative keratitis
por: Cordero-Coma, Miguel, et al.
Publicado: (2012) -
Update on peripheral ulcerative keratitis
por: Yagci, Ayse
Publicado: (2012) -
Anti-IL-6 Receptor Tocilizumab in Refractory Graves’ Orbitopathy: National Multicenter Observational Study of 48 Patients
por: Sánchez-Bilbao, Lara, et al.
Publicado: (2020) -
Peripheral Ulcerative Keratitis with Pyoderma Gangrenosum
por: Imbernón-Moya, Adrián, et al.
Publicado: (2015)